These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24801096)

  • 1. Subcutaneous implantable cardioverter-defibrillator in a young woman.
    Calvagna GM; Ceresa F; Patanè S
    Int J Cardiol; 2014 Aug; 175(2):e30-2. PubMed ID: 24801096
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonthoracotomy cardioverter defibrillator implantation in a 2-year-old infant with long QT syndrome.
    Schreiber C; Kostolny M; Eicken A; Lange R
    Ann Thorac Surg; 2006 Jun; 81(6):e27-8. PubMed ID: 16731109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-incision technique for the subcutaneous implantable cardioverter defibrillator.
    Nomura Y; Kato T; Nishihara E; Morishima I; Kuraishi K
    Pediatr Int; 2020 Jun; 62(6):736-738. PubMed ID: 32424905
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.
    Sundström E; Jensen SM; Diamant UB; Rydberg A
    Scand Cardiovasc J; 2017 Apr; 51(2):88-94. PubMed ID: 27936942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pocket infection as a complication of a subcutaneous implantable cardioverter-defibrillator.
    Calvagna GM; Ceresa F; Patanè S
    Int J Cardiol; 2014 Dec; 177(2):616-8. PubMed ID: 25443252
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a role for implantable cardioverter defibrillators in long QT syndrome?
    Welde AA
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1 Suppl):S110-3. PubMed ID: 11852886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 18-Year-Old Woman Who Was Found Down.
    Kawji MM; Glancy DL
    Am J Cardiol; 2017 Apr; 119(7):1124-1125. PubMed ID: 28132684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [QTc variability. Is a single measurement of QT/QTc interval enough to perform risk stratification and therapeutic decisions in a patient with long QT syndrome?].
    Zienciuk-Krajka A; Kukla P; Pazdyga A; Krajka P; Raczak G
    Kardiol Pol; 2013; 71(3):295-9. PubMed ID: 23575789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmic effect of pacing mode reprogramation in a patient with a congenital long-QT syndrome.
    Di Cori A; Zucchelli G; Romano S; Bongiorni MG
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1304-5. PubMed ID: 23758507
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Completely subcutaneous implantable cardioverter defibrillator: Care of S-ICD wearers during childbirth].
    Strewe C; Fichtner S
    Anaesthesist; 2015 Nov; 64(11):843-5. PubMed ID: 26341078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous implantable cardioverter-defibrillator technology.
    Gupta A; Al-Ahmad A; Wang PJ
    Heart Fail Clin; 2011 Apr; 7(2):287-94, x. PubMed ID: 21439506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous array with active can implantable cardioverter defibrillator configuration: a follow-up study.
    Kaltman JR; Gaynor JW; Rhodes LA; Buck K; Shah MJ; Vetter VL; Madan N; Tanel RE
    Congenit Heart Dis; 2007; 2(2):125-9. PubMed ID: 18377489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R; Porter CB; Ackerman MJ
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting the right defibrillator in the younger patient: Transvenous, epicardial or subcutaneous?
    Bogush N; Espinosa RE; Cannon BC; Wackel PL; Okamura H; Friedman PA; McLeod CJ
    Int J Cardiol; 2018 Jan; 250():133-138. PubMed ID: 29169751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implantation of cardioverter-defibrillator in treatment of congenital long QT syndrome in a child].
    Liu QM; Wang C; Zhou SH
    Zhonghua Er Ke Za Zhi; 2008 May; 46(5):400. PubMed ID: 19099771
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome.
    Groh WJ; Silka MJ; Oliver RP; Halperin BD; McAnulty JH; Kron J
    Am J Cardiol; 1996 Sep; 78(6):703-6. PubMed ID: 8831415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
    Zaki A; Zaidi A; Newman WG; Garratt CJ
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.